top of page

LayerBio's OcuRing-K ketorolac devise has potential to disrupt NSAID delivery in cataract surgery

Featured Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen attends ACS Fall 2018 National Meeting!

CreaGen attends ACS Fall 2018 National Meeting!

C2I hosts exciting private summer social!

C2I hosts exciting private summer social!

CreaGen Life Science Incubator (C2I) is expanding!

CreaGen Life Science Incubator (C2I) is expanding!

6th Annual Advances in Chemical Sciences Symposium

6th Annual Advances in Chemical Sciences Symposium

Recent Posts

Welcome to our member, 100X Bioassay!

We are extending a warm welcome to our new member, Fieldstone Bio, Inc.!

C2I Accelerator 2023 Summer Mixer

Bioactivity Supports Premature Infants’ Immunity, Development, and Growth, According to a Review

ODDITY Invests $100M to Bring Revela's AI-Based Molecule Discovery Technology to Beauty and Wellness

Thank you for attending our panel discussion, Strategies to Advance Startups in Today's Environment!

Save the Date: Strategies to Advance Startups in Today's Environment

Welcome AlpaLifeB INC!

NESACS VIRTUAL October Meeting Features Dr. Murat Cirit, CEO & Co-Founder of Javelin Biotech!

Congratulations to our partner, Middlesex Community College, on the opening of their lab facility!

Follow Us

bottom of page